In pursuit of better anti-HIV agents, QSAR studies were performed on a series of 1, 1, 3 -trioxo [1, 2, 4] -thiadiazine (TTDs) analogues. Stepwise multiple linear regression analysis was performed to derive QSAR models which were further evaluated for statistical significance and predictive power by internal and external validation. The best QSAR model was selected, having correlation coefficient (r) = 0.864, standard error of estimation (SEE) = 0.443 and cross validated squared correlation coefficient (q 2 ) = 0.623. The predictive ability of the selected model was also confirmed by leave 20 % out cross validation. The QSAR model indicates that the thermodynamic descriptors (molar refractivity), electronic descriptor (ionization potential), Hansen-polarity and hydrogen bond donor play an important role for the anti-HIV activities. The results of the present study may be useful on the designing of more potent TTDs analogues as anti-HIV agents.
Introduction
HIV-1 (Human Immunodeficiency Virus Type-1) is the pathogenic retrovirus and causative agent of AIDS or AIDS-related complex (ARC). 1, 2 When viral RNA is translated into a polypeptide sequence, it is assembled in a long polypeptide chain, which includes several individual proteins namely, reverse transcriptase, protease, integrase, etc. Before these enzymes become functional, they must be cut from the longer polypeptide chain. HIV is a retrovirus of the lentivirus family. 3 The three viral enzymes of HIV play an important role in the virus replication cycle. Among them, viral reverse transcriptase (RT) catalyzes the formation of proviral DNA from viral RNA, the key stage in viral replication. Its central role in viral replication makes RT a prime target for anti-HIV-therapy.
Two main categories of HIV RT inhibitors have been discovered to date. The first category of inhibitors is nucleoside analogues (e.g., AZT, 3TC, ddI, ddC) and the second category of inhibitors is nonnucleoside analogues. Nevirapine, delaviridine and efavirenz are the only nonnucleoside reverse transcriptase inhibitors (NNRTI) that have received regulatory approval. Several NNRTIs (MKC442, Troviridine, S-1153/ AG1549. PNU142721, ACT and HBY1293/GW420867X) are currently undergoing clinical trials. Efavirenz was the first potent anti-HIV drug to be approved by FDA and studies have shown that efavirenz penetrates into the cerebrospinal fluid, a common viral sanctuary. The therapeutic efficacy of the drug is mainly restricted due to the development of viral resistance associated with mutations that includes K103N, L1001 and Y188L. 5 Comparative molecular field analysis (CoMFA) and Comparative molecular similarity indices analysis (CoMSIA) are powerful and versatile tools to build and design an activity model (QSAR) for a given set of molecules in rational drug design and related applications, 6, 7 HIV-1 reverse transcriptase inhibitors, [8] [9] [10] HIV-1 protease inhibitors [11] [12] [13] [14] [15] and HIV-1 integrase inhibitors [16] [17] [18] and gp 120 envelope glycoprotein. 19 In search of effective TTDs analogues with minimal viral resistance problems, Arranz M. E. et al, 20 synthesized and evaluated a novel set of TTDs for their anti-HIV activity. Standard deviation of anti-viral activity and the structural difference between the compounds in the selected series are high. It insists as to select these series of compounds for our QSAR studies. All the anti-HIV activities used in the present study were expressed as pEC 50 = -log 10 EC 50 , where EC 50 is the micro molar concentration of the compounds producing 50% reduction in the cytopathic effect caused by the virus is stated as the means of at least two experiments. EC 50 values were assessed by MTT assay. The compounds which were not showing confirmed anti-HIV activity in the above cited literature have not been taken for our study.
Results and Discussion
A data set of 33 compounds for anti-HIV activity was used for the present QSAR study. In the above equations n is the number of compounds used to derive the model and values in parentheses are the 95% confidence limit of respective coefficient. We extended our study for five-parametric correlations as they are permitted for a data set of 33 compounds in accordance with the lower limit of rule of thumb. The calculated and predicted (LOO) activities of the compounds by the above models are shown in Table 2 .
Model 
(y exp -y pred ) 2 (y exp -y tr ) 2 Where is the averaged value for the dependent variable for the training set. 
Experimental Section
General Procedures. Win CAChe 6.1 (molecular modeling software, a product of Fujitsu private limited, Japan), Molecular modeling pro 6.1.0 (trial version, Cambridge software Corp.), STATISTICA version 6 (StatSoft, Inc., Tulsa, USA).
Optimization of molecules structure
All 33 TTDs structures were built on workspace of Win CAChe 6.1 (molecular modeling software, a product of Fujitsu private limited, Japan) and energy minimization of the molecules was done using Allinger's MM2 force field followed by semi empirical PM3 method available in MOPAC module until the root mean square gradient value becomes smaller than 0.001 kcal/mol Å. Most stable structure for each compound was generated and used for calculating various physicochemical descriptors like thermodynamic, steric and electronic values of descriptors.
Descriptors calculation, QSAR models development and validation
All the calculated descriptors (50 descriptors calculated by Win CAChe 6.1 and Molecular modeling pro 6.1.0, and 3 indicator variables, the complete descriptors data set of all compounds will be provided on request) were considered as independent variable and biological activity as dependent variable. STATISTICA version 6 (StatSoft, Inc., Tulsa, USA) software was used to generate QSAR models by stepwise multiple linear regression analysis. Statistical measures used were n-number of compounds in regression, r-correlation coefficient, r 2 -squared correlation 
